Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Canlim Capsules
- Development stage
- Unknown
- Lead developer
- Xian CP
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Canlim Capsules (also known as Canelim Capsules or Pingxiao Capsules) is a traditional Chinese medicine (TCM) anticancer preparation developed and marketed by Xian Zhengda Pharmaceutical. It is officially authorized and approved in China as an adjuvant therapy for oncology indications, including breast cancer, and is listed in China's State Basic Medicinal Insurance Drugs catalogue. The formulation consists of a mixture of traditional Chinese herbs, including Strychnos nux-vomica, Curcuma wenyujin, Agrimonia pilosa, Toxicodendron vernicifluum, Trogopterus dung, alumen, potassium nitrate, and Citrus aurantium. It is administered orally and is used to inhibit tumor growth, reduce tumor size, relieve cancer pain, and enhance immune function, often in combination with radiotherapy or chemotherapy.
- Brand names
- Canelim CapsulesCanlim CapsulesPingxiao CapsulesPingxiao Tablets
- Other names
- PXCPingxiao平消片平消胶囊
Beyond the preview
Go deeper on Canlim Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canlim Capsules.